HBP News Alert Huttig Bldg Products (HBP) 3.14 12/17/2014 03

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Huttig Bldg Products (HBP) 3.14 $HBP

Helix BioPharma Corp. Announces Q1 Fiscal 2015 Results
Marketwire Canada - Mon Dec 15, 4:21PM CST
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the first quarter of fiscal 2015, ended October 31, 2014.
HBP: 3.14 (-0.01), HBP.TO: 1.56 (-0.09)

Comparing The 3 Largest Building Materials Wholesale Companies
Joseph Cafariello - at Seeking Alpha - Mon Dec 15, 9:12AM CST

HBP: 3.14 (-0.01), BXC: 1.14 (unch), LPX: 15.54 (-0.25)

Helix BioPharma Corp. to Explore Growth Opportunities
Marketwire Canada - Thu Dec 04, 4:38PM CST
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced that the Company has begun a comprehensive exploration of growth opportunities available to it.
HBP: 3.14 (-0.01), HBP.TO: 1.56 (-0.09)

Huttig Building Products, Inc. Announces Third Quarter 2014 Results
Marketwired - Thu Oct 30, 5:00AM CDT
Huttig Building Products, Inc. (Huttig, or the Company) (NASDAQ: HBP), a leading domestic distributor of millwork, building materials and wood products, today reported financial results for the third quarter ended September 30, 2014.
HBP: 3.14 (-0.01)

Helix BioPharma Corp. Announces Fiscal 2014 Results
Marketwire Canada - Thu Oct 23, 7:35PM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the year ended July 31, 2014.
HBP: 3.14 (-0.01), HBP.TO: 1.56 (-0.09)

Helix Reports on Interim Review of the Polish L-DOS47 Monotherapy Study in Non-Small Cell Lung Cancer
Marketwire Canada - Tue Sep 30, 7:31AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has completed its interim data review of the first eight cohorts of the Company's ongoing Phase I/II clinical safety, tolerability and preliminary efficacy study of L-DOS47 in Poland ("LDOS002" .
HBP: 3.14 (-0.01), HBP.TO: 1.56 (-0.09)

Helix BioPharma Corp. Initiates Enrollment for Tenth Cohort in Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47
Marketwire Canada - Fri Sep 26, 4:00PM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the opening of patient screening for the tenth dose level cohort in its ongoing Phase I/II clinical safety, tolerability and preliminary efficacy study of L-DOS47 in Poland ("LDOS002" .
HBP: 3.14 (-0.01), HBP.TO: 1.56 (-0.09)

Helix BioPharma Corp. to Present at the 2nd Global Life Sciences Conference in Warsaw, Poland
Marketwire Canada - Thu Sep 25, 4:00PM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it will be presenting at the 2nd Global Life Sciences Conference to be held on October 2, 2014 in Warsaw, Poland, on the trading floor of the Warsaw Stock Exchange. The conference is sponsored by WedBush Europe and WDM Capital. Over 100 of Central and Eastern Europe's top life science institutional investors, funds, and analysts are expected to attend the Conference.
HBP: 3.14 (-0.01), HBP.TO: 1.56 (-0.09)

Huttig Building Products, Inc. Announces Second Quarter 2014 Results
Marketwire - Thu Jul 31, 5:01AM CDT
Huttig Building Products, Inc. (Huttig, or the Company) (NASDAQ: HBP), a leading domestic distributor of millwork, building materials and wood products, today reported financial results for the second quarter ended June 30, 2014.
HBP: 3.14 (-0.01)

Helix BioPharma Corp. Appoints New Independent Chair of the Board
Marketwire Canada - Mon Jul 21, 8:15AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced the appointment of Mr. Yvon Bastien as the new Chair of the board effective July 17, 2014. Mr. Bastien has served as an independent director of the Company since December 2013 and remains the Chair of the board's Governance & Compensation Committee. Mr. Robert Verhagen has served as Interim Chair since December 2013 and remains a Director of the Company and President and CEO.
HBP: 3.14 (-0.01), HBP.TO: 1.56 (-0.09)

Helix BioPharma Corp. Announces Completion of Private Placement
Marketwire - Fri Jul 11, 7:00AM CDT
Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has completed a private placement with net proceeds in excess of CAD5.4 million, after fees and expenses associated with the placement.
HBP: 3.14 (-0.01), HBP.TO: 1.56 (-0.09)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 172

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 134

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 154

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 71

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 118

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Lyft Upgraded to Buy: Insights for Future Growth Potential

Updated Category News Views 292

Lyft's Upgrade by Benchmark: A Closer Look Benchmark analysts have recently upgraded Lyft (NASDAQ: LYFT) from Hold to Buy, highlighting what's described as "significant optionality" for the rideshare company. This decision comes despite the heightened competition from major players like Tesla and Waymo, indicating confidence in Lyft's capability to navigate potential...

Continue Reading
LiveOne Board Changes Amid Expansion and Financial Growth

Updated Category News Views 120

LiveOne Announces Departure of Board Member LiveOne, Inc. (NASDAQ:LVO) has recently made headlines in the retail-eating sector with the announcement of Craig Foster's resignation from its board of directors. Foster, who also contributed to the Audit Committee and Nominating and Corporate Governance Committee, stepped down to focus on his other professional commitments....

Continue Reading
Concorde International Group's Remarkable 80% After-Hours Surge

Updated Category News Views 429

Concorde International Group's Stock Surge Explained Concorde International Group Ltd. (NASDAQ: CIGL) has captured attention in the stock market after experiencing an impressive 80.16% increase during after-hours trading, reaching a price of $4.63. Investors are buzzing and speculating about what led to this dramatic leap. Exciting New Equity Incentive Plan Announced The...

Continue Reading
Celebrating the Legacy of Dr. Iain Douglas-Hamilton

Updated Category News Views 301

Special Screenings of A Life Among Elephants In a remarkable celebration of conservation, special screenings of the inspiring film A Life Among Elephants will honor the legacy of Dr. Iain Douglas-Hamilton. This film encapsulates the essence of his lifelong dedication to elephant conservation, portraying not only the threats faced by these majestic creatures but also the...

Continue Reading
Saudi Arabia Launches Major SME Report at Biban24 Event

Updated Category News Views 75

Saudi Arabia Presents Key Economic Insights at Biban24 As Saudi Arabia continues its path toward achieving ambitious Vision 2030 objectives, Monsha'at, the authority dedicated to small and medium enterprises (SMEs), is hosting Biban24. This significant event, designed to promote entrepreneurship and growth opportunities, brings together global entrepreneurs and investors...

Continue Reading